Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F ( Mark One ) REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report_ Commission file number 001-39822 Pharming Group N.V. ( Exact name of registrant as specified in its charter ) The Netherlands 2834 Not applicable ( Jurisdiction of incorporation or organization ) ( Primary Standard Industrial Classification Code Number ) ( Translation of Registrant's name into English ) Darwinweg 24 2333 CR Leiden The Netherlands Tel : +31 ( 0 ) 71 5247 400 ( Address , including zip code , and telephone number , including area code , of registrant's principal executive offices ) Pharming Healthcare Inc. 10 Independence Blvd , 4th Floor Warren , New Jersey 7059 +1 908 524 0888 ( Name , address , including zip code , and telephone number , including area code , of agent for service ) Title of each class Securities registered or to be registered pursuant to Section 12 ( b ) of the Act . American Depositary Shares , each representing ten ordinary shares , nominal value EUR 0.01 per share Trading Symbol ( s ) PHAR Name of each exchange on which registered The Nasdaq Stock Market LLC The Nasdaq Stock Market LLC * Securities registered or to be registered pursuant to Section 12 ( g ) of the Act . None Ordinary shares , nominal value EUR 0.01 per share *